ArticleThe European respiratory journal2023

GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection.

Cheng Xiang Foo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.